Inventor

Laszlo Vertesy

Inventor
Eppstein, DE

Overview

42→
Patents
1980–2013
Patent span
Chemistry
Primary field (CPC C)

Patents· 42 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07KPeptides14%
A61KPreparations for medical, dental or toiletry purposes13%
C12NMicroorganisms or enzymes11%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture10%
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms8%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests7%
C07DHeterocyclic compounds6%
C07HSugars5%
C07CAcyclic or carbocyclic compounds3%
PatentTitleYear
8,476,222'Isolated peptides from Actinomadura namibiensis'20137,259,276'Polyenecarboxylic acid derivatives, processes for preparing them, and their use'20077,253,206'Phenalenone derivatives, processes for preparation and use thereof'20077,148,254'2-Phenylbenzofuran derivatives, a process for preparing them, and their use'20067,067,112'Cephaibols: novel antiparasitics from Acremonium tubakii, process for their production, and use thereof'20066,927,236'Coniosulfides and their derivatives, processes for preparing them, and their use as pharmaceuticals'20056,756,402'Cyclipostins, process for their preparation and use thereof'20046,673,834'Hydroperylene derivatives'20046,627,604'Memno peptides, process for their preparation and use thereof'20036,624,143'Calcium salts of lipopeptide antibiotics, method for producing same and their use'20036,599,930'Coniosetin and derivatives thereof, process for the preparation and the use thereof'20036,582,949'Cephaibols: novel antiparasitics from Acremonium tubakii process for their production, and use thereof'20036,579,903'Klainetins and their derivatives, method for their preparation and use thereof'20036,500,936'Pluraflavins and derivatives thereof, process for their preparation and use thereof'20026,472,158'Ustilipides, method for the production and the use thereof'20026,380,257'Aromatic di-keto derivatives, processes for their production and their use as a pharmaceutical'20026,194,383'Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof'20016,166,070'Kodaistatins A, B, C and D, a process for their production and their use'20006,077,830'Bismuth salts of antibiotics of the moenomycin group, processes for their preparation, their use and pharmaceuticals comprising such salts'20006,022,851'Lantibiotic related to actagardine, and processes for the preparation and use thereof'20005,994,307'Methods of treatment with novel antibiotic feglymycin'19995,986,089'Process for the preparation of moenomycin A'19995,939,399'Polyene antibiotics, 3874 H1 to H6, processes for their preparation and use'19995,891,851'Antibiotic, feglymycin, processes for its preparation and its use'19995,763,397'Glycopeptides, a process for their preparation and their use'19985,721,208'Glycopeptides a process for their preparation and their use'19985,719,121'Use of balhimycin as production promoter in animals, and production promoter compositions'19985,519,123'Chelating agents, their preparation from the antibiotics salmycin A,B,C, or D, and their use'19965,506,202'Insulin derivatives, a process for the preparation thereof, the use thereof, and a pharmaceutical formulation containing them'19965,475,094'Salmycins, a process for their preparation and their use as a pharmaceutical'19955,302,582'Enkastins: new glycopeptides which act to inhibit enkephlinase, processes for their preparation, and their use as pharmaceutical products'19945,149,716'Insulin derivatives, process for their preparation, their use and a pharmaceutical preparation containing them'19925,091,524'Glycosidase inhibitor salbostatin, process for its preparation, and its use'19924,990,500'Oxirane pseudooligosaccharides, a process for their preparation, their use and pharmaceutical preparations'19914,632,917'Pseudooligosaccharides with an .alpha.-glucosidase-inhibiting action, their use and pharmaceutical products'19864,623,714'Novel polypeptides with an .alpha.-amylase-inhibiting action, a process for their preparation, their use and pharmaceutical products'19864,618,602'Amine containing pseudooligosaccharide, pharmaceutical composition and method of use'19864,451,455'.alpha.-Amylase inactivator, a process for its preparation, an agent based on this inactivator and its use'19844,339,436'.alpha.-Amylase inhibitor from a streptomycete and process for its preparation'19824,282,318'.alpha.-Amylase inhibitor from a streptomycete and process for its preparation'19814,226,764'.alpha.-Amylase inhibitor from a streptomycete and process for its preparation'19804,204,058'Process for obtaining cephalosporin C and the salts and derivatives thereof from culture filtrates or culture solutions'1980

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1980–2001Patents assigned to HOECHST AG (24)· patent assignee history
1980–2006Based in Eppstein, DE· patent location history
2000–2005Patents assigned to AVENTIS PHARMA GMBH (12)· patent assignee history
2002–2013Based in Eppstein-Vockenhausen, DE· patent location history
2006–2007Patents assigned to SANOFI AVENTIS DEUTSCHLAND (4)· patent assignee history
2013Patents assigned to BROENSTRUP MARK (1)· patent assignee history
2013Patents assigned to GUEHRING HANS (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
HOECHST AG241980–2001
AVENTIS PHARMA GMBH122000–2005
SANOFI AVENTIS DEUTSCHLAND42006–2007
BROENSTRUP MARK12013
GUEHRING HANS12013
Locations
LocationPatentsSpan
Eppstein, DE311980–2006
Eppstein-Vockenhausen, DE112002–2013